Let the fundraising begin! At a press conference today, the Oregon Health & Science University (OHSU) authorities have announced plans to raise $ 500 million for cancer research over the next 2 years to win a grant equivalent consideration. The challenge of $ 500 million was offered last Friday in a surprise move by philanthropists Phil and Penny Knight. The campaign of $ 1 billion "is a moment of transformation" for the university and the war against cancer, said OHSU President Joe Robertson.
The Knights had donated $ 100 million to create a research institute on cancer at OHSU, led by Brian Druker, who led development of the drug Gleevec against cancer. Their latest commitment was made after Druker has recently pressured the couple for $ 1 billion to take ideas to Gleevec, and other so-called molecularly targeted therapies, and develop more early tumor detection tools. Call the current methods of cancer detection "technology relatively crude," Druker said, "we must do better."
OHSU officials did not provide details of how they intend to spend the potential $ 1 billion, although Druker said it plans to hire about 20 scientific elite and give them sufficient funds to take risks, a strategy he compared to what the Howard Hughes medical Institute did. "We are trying to release the investigators of our current constraints of writing grant," he said.
Phil Knight was a co-founder Sports giant Nike shoes and is now a major contributor to academia. In 06 he gave the Business School of Stanford University which was, at that time the largest donation in its history, $ 105 million.
0 Komentar